CBL vs NAN

ASX Healthcare sector comparison — updated 23 Jul 2026 — Healthcare sector

CBL

CTRLBIONIC FPO [CBL]

51MEDIUM

NAN

NANOSONICS FPO [NAN]

51MEDIUM

Score Breakdown

CBL NAN
Technical
63
48
Catalyst
61
51
Sentiment
50
50
Fundamental
46
94
Momentum
75
38
Risk Gate
50
40

Key Metrics

CBL Metric NAN
$31.2MMarket Cap$899.7M
571KAvg Volume (20d)423K
N/AShort Interest+6.8%
$0.09552-Week High$4.770
$0.03252-Week Low$2.960
+6.1%Daily Change-0.7%
$0.070Reference Price$3.030
-91.6%ROE+10.1%
-107.0%Profit Margin+9.9%

Active Signals

CBL Signals

RSI drifting toward oversold territory — worth watching
Stochastic just turned bullish from a low level — early reversal sign
Trading below both moving averages — the trend is working against this one
Above-average volume (1.8x) on a green day — buyers stepping up
Lagging the Small Ords index — relative strength of 0.86, underperforming its peers
Volatility is contracting — like a spring being compressed, breakouts often follow
Trading above the 200-day average — the long-term trend is on your side
Low cash runway (3 quarters) - dilution risk

NAN Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is losing steam
Stochastic is deep in oversold territory — bounce conditions forming
Sitting right at the lower Bollinger Band — oversold and potentially ready to snap back
Trading below both moving averages — the trend is working against this one
Sitting near support — this level has held before and could attract buyers again
Drifting lower — down 7.3% over the last 5 days
Below the 200-day average — the long-term trend is still working against it

Ask Scout AI to compare CBL and NAN in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

ACL vs NAN →IPD vs NYR →CBL vs NYR →ACL vs NYR →IPD vs LGP →
CBL Full Analysis → NAN Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).